Overview Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics Status: Completed Trial end date: 2008-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of VI-0521 compared to placebo in the glycemic management of obese diabetic adults. Phase: Phase 2 Details Lead Sponsor: VIVUS, Inc.Collaborator: Synteract, Inc.